Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
The Pharmacist Defence Association (PDA) has said that ‘regrettably’ some pharmacy companies and locum agencies are now threatening to refer locums, who are seeking to negotiate higher rates, to the GPhC.
The PDA has therefore sought to offer some clarity and reassurances to locum pharmacists about this issue.
The PDA has also said that they are aware that the GPhC has raised a concern about locums who may be exploiting the COVID-19 crisis.
In a recent statement the GPhC said the following;
“Profiteering to take selfish advantage of the current challenging situation, whether with prices of shortage products or locum rates, risks bringing the profession into disrepute at a time when public confidence generally is so fragile, and so important.”
In a statement issued on their website the PDA said the following:
“Rates for community pharmacy locum assignments must be individually negotiated between the locum and client or through a locum agency. This is an important element of a free market arrangement consistent with the expectations of the Competition and Markets Authority (CMA); the ability to negotiate prices for a job is a factor taken into account by the HMRC when determining the self-employed status of a locum. Please note there are separate rules and price caps for NHS agency pharmacists.”
The PDA has taken expert legal opinion and as such has said that it is unlawful for employers acting together, or by conspiring with a locum agency(ies) to seek to manipulate market rates and inhibit free-market conditions. The CMA has extensive enforcement powers in this respect including punitive fines and custodial sentences for directors and owners.
Where the PDA receives evidence of employers and other organisations acting unlawfully, they have said that they will have no hesitation in referring any anti-competitive cartel behaviour to the CMA, where necessary.
The PDA continued:
“It is important to recognise, that the same anti-competition rules for business also apply to locum pharmacists. Any chat rooms, organised groups or collectives of locums who discuss how they might seek to fix minimum market rates or boycott pharmacies and particularly those who are seen to encourage others to take advantage of the pandemic situation, run a similar risk of being referred to the CMA by employers. The PDA is aware that complaints to the CMA have been made previously in recent years.
“Any pharmacist seen to be involved in such anti-competitive actions also runs the risk of damaging the reputation and the image of the profession, notwithstanding exposing themselves to a criminal investigation. This was demonstrated by the shameful behaviour of a chain of pharmacies selling paracetamol suspension for £19.99 which was recently reported extensively on national television.
“We fully understand the sentiments of the GPhC in so far as it relates to behaviour that could undermine wider public confidence in the profession and we support these concerns. However, the GPhC has no other legitimate regulatory interest in the commercial rates agreed between locums and their clients. To refer a locum to the GPhC for simply negotiating a higher hourly rate would be an absurdity and an abuse of the regulatory system.
“We know that in general rates have not kept up with inflation and since the global financial crisis, there have always been a range of rates agreed. This occurs with all products in the shops and services provided elsewhere; it is the basis of a free market economy operating under a supply and demand model.
The PDA has reminded pharmacists, companies and locum agencies that many factors influence negotiations around locum rates including:
You can read about some of PDA’s other activity on behalf of locums during this crisis period here.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.